Learning Objectives:

• After attending this presentation, learners will be able to:
• Interpret updated data on HIV transmission risk, including low-level viremia
• Evaluate innovative HIV testing strategies to improve diagnosis and linkage to care
• Compare oral and long-acting PrEP strategies, including real-world effectiveness
• Identify barriers to PrEP uptake, persistence, and equitable access
• Assess implementation challenges limiting the impact of HIV prevention strategies
• Evaluate emerging prevention approaches, including long-acting and novel agents
• Summarize evidence for doxycycline post-exposure prophylaxis (doxy-PEP)
• Balance benefits and risks of doxy-PEP, including antimicrobial resistance
• Assess emerging PEP strategies and their role in prevention
• Integrate HIV and STI prevention strategies into patient-centered care

Featured Speaker: 

William Mazur, MD- Medical Director, Holloway Community Program

CEUs

1 CME credit pending approval

Intended Audience

Holloway Community Program 

Contact